Lobbying Filing Details

Total Spending

$60,000

Activities

2

Lobbyists

4

Gov't Entities

3

Filing Information
Filing UUID:
68974659-b5c4-49fd-9cf7-0d1ae2d9c791
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2026 at 1:46 PM
Income:
$60,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Brian Pomper
Registrant
AKIN GUMP STRAUSS HAUER & FELD

Law firm

WASHINGTON, District of Columbia
Client
BIOTECHNOLOGY INNOVATION ORGANIZATION
District of Columbia, United States of America
Lobbying Activities (2)
Activity 1
Health Issues

Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262 / S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases; Issues related to the biotech ecosystem, including most-favored-nation drug pricing; Issues related to PBM reform, PAHPA reauthorization; and PDUFA reauthorization.

Lobbyists (3)
  • VIRGIL MILLER
  • ANNA ABRAM
  • MARA LEFEVRE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Small Business

Issues related to the Small Business Innovation Research Program in the Small Business Innovation and Economic Security Act (P.L. 119-83).

Lobbyists (1)
  • DAVID SCHWIETERT
Government Entities (1)
  • SENATE

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.